儿童过敏性紫癜复发研究进展
Research Progress on Recurrence of Anaphylactoid Purpura in Children
DOI: 10.12677/acm.2025.152392, PDF,   
作者: 谢 君：吉首大学医学院，湖南 吉首；周卫华：湘西自治州人民医院产前诊断中心，湖南 吉首；刘权娥*：湘西自治州人民医院小儿肾病风湿免疫内分泌呼吸专科，湖南 吉首；龙茂林：湘西自治州人民医院检验科，湖南 吉首
关键词: 过敏性紫癜；复发；危险因素；Henoch-Schonlein Purpura (HSP)； Recurrence； Risk Factor
摘要: 过敏性紫癜(Henoch-schonlein purpura, HSP)是儿童时期一种常见的血管炎，主要影响小动脉和毛细血管。HSP无特异性治疗，主要是对症治疗及并发症的治疗，大多数患儿预后良好，但仍有部分患儿可能会经历复发。HSP反复发作不仅严重损害患儿的身心健康，也给家庭及社会也带来了较重的经济负担，因此本文综述了HSP复发率、HSP复发临床表现及HSP复发相关危险因素，旨在为临床医师提供早期识别疾病复发和进行早期干预的理论依据。
Abstract: Henoch-schonlein purpura (HSP) is a common vasculitis in childhood that mainly affects small arteries and capillaries. There is no specific treatment for HSP, mainly symptomatic treatment and treatment of complications. Most children with HSP have a good prognosis, but some children may experience relapse. The recurrence of HSP not only seriously damages the physical and mental health of children, but also brings heavy economic burden to the family and society. Therefore, this paper reviews the recurrence rate of HSP, clinical manifestations of HSP recurrence and risk factors related to HSP recurrence, aiming to provide theoretical basis for early identification and early intervention of the disease for clinicians.
文章引用：谢君, 周卫华, 刘权娥, 龙茂林. 儿童过敏性紫癜复发研究进展[J]. 临床医学进展, 2025, 15(2): 661-665. https://doi.org/10.12677/acm.2025.152392

参考文献

[1] Gómez, S., Pérez, M., Pellegrini, M., et al. (2020) Henoch-Schonlein Purpura in Pediatrics: Ten Years of Experience at a Moderate Risk Office of a General Hospital. Archivos Argentinos de Pediatria, 118, 31-37.
[2] 赵亚斌. 过敏性紫癜患儿复发或反复情况的影响因素分析[J]. 山西医药杂志, 2019, 48(12): 1463-1464.
[3] Li, M., Guo, B., Wang, X. and Zhang, Y. (2021) Risk Factors of Renal Trauma in Children with Severe Henoch-Schonlein Purpura and Effect of Mycophenolate Mofetil on Pediatric Renal Function. Translational Pediatrics, 10, 3166-3174. [Google Scholar] [CrossRef] [PubMed]
[4] Song, D., Jiang, Y., Zhao, Q., et al. (2022) Development and Validation of a Nomogram to Predict Recurrence in Children with Henoch-Schönlein Purpura. American Journal of Translational Research, 14, 4688-4697.
[5] Zhou, J., Li, L., Luo, J., Yang, Y. and Shen, X. (2022) Association between Common Laboratory Indices and IGAV Recurrence in Children. BMC Pediatrics, 22, Article No. 606. [Google Scholar] [CrossRef] [PubMed]
[6] 余丽娟, 汤玉霞, 余竹春, 等. IL-17、IgA、IgE在过敏性紫癜患儿中的表达及影响患儿复发的危险因素分析[J]. 现代预防医学, 2023, 50(1): 86-90.
[7] 宁晓洁, 史丽娜, 吕婷婷, 等. 过敏性紫癜儿童复发影响因素研究[J]. 华南预防医学, 2024, 50(3): 277-279+283.
[8] 朱凯莉, 黄燕萍, 刘丽, 等. 基于Cox回归分析的儿童过敏性紫癜复发危险因素研究[J]. 西安交通大学学报(医学版), 2023, 44(2): 283-287.
[9] 江载芳, 王天有, 申昆玲, 沈颖, 倪鑫, 刘小梅, 马琳, 马晓莉, 王天有. 诸福棠实用儿科学(下) [M]. 北京: 人民卫生出版社, 2022.
[10] Cao, T., Yang, H., Huang, J. and Hu, Y. (2023) Risk Factors Associated with Recurrence of Henoch-Schonlein Purpura: A Retrospective Study. Frontiers in Pediatrics, 11, Article ID: 1164099. [Google Scholar] [CrossRef] [PubMed]
[11] Lei, W., Tsai, P., Chu, S., Kao, Y., Lin, C., Fang, L., et al. (2018) Incidence and Risk Factors for Recurrent Henoch-Schönlein Purpura in Children from a 16-Year Nationwide Database. Pediatric Rheumatology, 16, Article No. 25. [Google Scholar] [CrossRef] [PubMed]
[12] Hetland, L., Susrud, K., Lindahl, K. and Bygum, A. (2017) Henoch-Schönlein Purpura: A Literature Review. Acta Dermato Venereologica, 97, 1160-1166. [Google Scholar] [CrossRef] [PubMed]
[13] 于云和, 王冰. 减少运动量在过敏性紫癜治疗中的临床意义[J]. 吉林医学, 2015, 36(7): 1420-1421.
[14] 张艳, 宋晓彤, 王云, 等. 过敏性紫癜患儿复发的影响因素及IgE、IgA水平对其预测价值[J]. 分子诊断与治疗杂志, 2021, 13(12): 2034-2037.
[15] 江雅静, 宋丹阳, 李金玲. 血液及炎症指标对过敏性紫癜患儿复发风险的预测价值[J]. 中国实验血液学杂志, 2023, 31(3): 837-842.
[16] Shi, D., Chan, H., Yang, X., Zhang, G., Yang, H., Wang, M., et al. (2019) Risk Factors Associated with Iga Vasculitis with Nephritis (Henoch-Schönlein Purpura Nephritis) Progressing to Unfavorable Outcomes: A Meta-Analysis. PLOS ONE, 14, e0223218. [Google Scholar] [CrossRef] [PubMed]
[17] Demircioğlu Kılıç, B. (2018) Determination of Risk Factors in Children Diagnosed with Henoch-Schönlein Purpura. Archives of Rheumatology, 33, 395-401. [Google Scholar] [CrossRef] [PubMed]
[18] 黄国英, 孙锟, 罗小平. 全国高等学校教材 儿科学[M]. 第10版. 北京: 人民卫生出版社, 2024.
[19] 杨扬, 唐帅, 张建. 过敏性紫癜患儿IgA D-D FDP水平与疾病复发的关系[J]. 河北医学, 2024, 30(3): 484-487.
[20] 孙培静, 刘海霞, 张心梅. 过敏性紫癜患者血清中过敏原特异性IgE和总IgE水平及临床意义[J]. 中国实验诊断学, 2021, 25(6): 821-824.
[21] 伍文彪. D-二聚体和纤维蛋白降解产物(FDP)在过敏性紫癜的临床应用及研究进展[J]. 临床医药文献电子杂志, 2020, 7(40): 194+196.
[22] Fan, L., Liu, H., Wang, Y.C., et al. (2017) Association of Serum Vitamin D Level with Severity and Treatment in Children with Henoch-Schönlein Purpura. Chinese Journal of Contemporary Pediatrics, 19, 796-799.
[23] 潘长鹭, 王美辰, 赵文利, 等. 儿童过敏性紫癜的营养状况和25-羟基维生素D3水平的临床研究[J]. 中国医刊, 2024, 59(8): 879-881.
[24] 吴盈盈, 叶欢欢, 周海燕. 小儿过敏性紫癜复发的危险因素分析和风险预测模型构建[J]. 中国妇幼保健, 2022, 37(22): 4214-4218.
[25] 雷丽. 维生素D缺乏的过敏性紫癜患儿外周血T细胞亚群、NK细胞计数变化[J]. 山东医药, 2018, 58(19): 67-69.
[26] 中华医学会儿科学分会免疫学组, 中华儿科杂志编辑委员会, 中国儿童风湿免疫病联盟. 中国儿童IgA血管炎诊断与治疗指南(2023) [J]. 中华儿科杂志, 2023(12): 1067-1076.

为你推荐